Victims Of Socialism
By INVESTOR'S BUSINESS DAILY | Posted Friday, March 06, 2009 4:20 PM PT
Deadly Rationing: The gatekeeper for Great Britain's national health care system is denying cancer patients drugs that would extend their lives. Why? Because the medication is considered too expensive.
What's a life worth? Apparently not much in Great Britain.
The National Institute for Health and Clinical Excellence, the government agency that decides which treatments the National Health Service will pay for, has effectively banned Lapatinib, a drug that was shown to slow the progression of breast cancer, and Sutent, which is the only medicine that can prolong the lives of some stomach cancer patients.
Banning beneficial drugs due to cost is nothing new in Britain. NICE, which has to be one of history's most ironic acronyms, forbade the use of Tarceva, a lung cancer drug proven to extend patients' lives, and Abatacept, even though it's one of the only drugs that has been shown in clinical testing to improve severe rheumatoid arthritis.
Once again, we have to ask: Do we really want to use the British system as the model for a U.S. health care regime? more...
Tuesday, March 17, 2009
Obama must fail in Socialized medicine!!
Socialised medicine will kill...without care...without cause...without reason.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment